Literature DB >> 18181047

Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.

Hongwei Tang1, Jun Wang, Feihu Bai, Huihong Zhai, Juan Gao, Liu Hong, Huahong Xie, Faming Zhang, Mei Lan, Wenzhu Yao, Jie Liu, Kaichun Wu, Daiming Fan.   

Abstract

Osteopontin (OPN), cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) are overexpressed in various experimental models of malignancy. However, the correlation and role of the three molecules in gastric cancer is unclear. In the present study, we found that OPN, COX-2 and VEGF were overexpressed in 53 cancerous tissues with gastric cancer compared with 40 normal mucosa tissues by immunohistochemistry method. Moreover, the results indicated co-expression of OPN, COX-2, and VEGF in gastric cancer. Levels of OPN, COX-2, and VEGF were all significantly correlated with TNM stage, lymph node metastasis and distant metastasis (P < 0.05), while not related to prognosis of patients. In addition, individual levels of OPN, COX-2, and VEGF were all significantly correlated with microvessel density (MVD), valued by CD34 staining directly with r-values of 0.416, 0.400, and 0.566, respectively (P < 0.01). Both OPN and COX-2 levels showed a positive correlation with VEGF (P < 0.05). Meanwhile, expression of COX-2 is in relation to OPN (P < 0.01). Overall, survival for patients with high MVD was significantly lower than for patients with low MVD (P < 0.05). Our findings indicate that OPN, COX-2, and VEGF synergically promote angiogenesis and metastasis in gastric cancer. It may be an important and useful strategy to target these molecules for prevention and therapy of tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181047     DOI: 10.1080/07357900701519279

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  20 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

Review 2.  Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.

Authors:  M P Bernard; S Bancos; P J Sime; R P Phipps
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 3.  Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis.

Authors:  Jian Song; Hong Su; Yang-Yang Zhou; Liang-Liang Guo
Journal:  Dig Dis Sci       Date:  2013-11-01       Impact factor: 3.199

4.  Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.

Authors:  Jing Chen; Tao Li; Yuanyuan Wu; Lijun He; Li Zhang; Tieliu Shi; Zhengfang Yi; Mingyao Liu; Xiufeng Pang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-15       Impact factor: 4.553

Review 5.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

Review 6.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

7.  Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.

Authors:  Maria Di Bartolomeo; Filippo Pietrantonio; Alessandro Pellegrinelli; Antonia Martinetti; Luigi Mariani; Maria Grazia Daidone; Emilio Bajetta; Giuseppe Pelosi; Filippo de Braud; Irene Floriani; Rosalba Miceli
Journal:  Gastric Cancer       Date:  2015-04-11       Impact factor: 7.370

8.  Aberrant expression of osteopontin and E-cadherin indicates radiation resistance and poor prognosis for patients with cervical carcinoma.

Authors:  Xinqiong Huang; Yujie Qian; Hainan Wu; Xiaoxue Xie; Qin Zhou; Ying Wang; Weilu Kuang; Lin Shen; Kai Li; Juan Su; Liangfang Shen; Xiang Chen
Journal:  J Histochem Cytochem       Date:  2014-11-07       Impact factor: 2.479

9.  Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.

Authors:  Yi-Fang Han; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 10.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.